263 related articles for article (PubMed ID: 26162744)
1. UDP-hexose 4-epimerases: a view on structure, mechanism and substrate specificity.
Beerens K; Soetaert W; Desmet T
Carbohydr Res; 2015 Sep; 414():8-14. PubMed ID: 26162744
[TBL] [Abstract][Full Text] [Related]
2. The metastability of human UDP-galactose 4'-epimerase (GALE) is increased by variants associated with type III galactosemia but decreased by substrate and cofactor binding.
Pey AL; Padín-Gonzalez E; Mesa-Torres N; Timson DJ
Arch Biochem Biophys; 2014 Nov; 562():103-14. PubMed ID: 25150110
[TBL] [Abstract][Full Text] [Related]
3. Comparison of dynamics of wildtype and V94M human UDP-galactose 4-epimerase-A computational perspective on severe epimerase-deficiency galactosemia.
Timson DJ; Lindert S
Gene; 2013 Sep; 526(2):318-24. PubMed ID: 23732289
[TBL] [Abstract][Full Text] [Related]
4. Chemical and stereochemical actions of UDP-galactose 4-epimerase.
Frey PA; Hegeman AD
Acc Chem Res; 2013 Jul; 46(7):1417-26. PubMed ID: 23339688
[TBL] [Abstract][Full Text] [Related]
5. In silico prediction of the effects of mutations in the human UDP-galactose 4'-epimerase gene: towards a predictive framework for type III galactosemia.
McCorvie TJ; Timson DJ
Gene; 2013 Jul; 524(2):95-104. PubMed ID: 23644136
[TBL] [Abstract][Full Text] [Related]
6. The structural basis of substrate promiscuity in UDP-hexose 4-epimerase from the hyperthermophilic Eubacterium Thermotoga maritima.
Shin SM; Choi JM; di Luccio E; Lee YJ; Lee SJ; Lee SJ; Lee SH; Lee DW
Arch Biochem Biophys; 2015 Nov; 585():39-51. PubMed ID: 26344854
[TBL] [Abstract][Full Text] [Related]
7. 13C NMR analysis of electrostatic interactions between NAD+ and active site residues of UDP-galactose 4-epimerase: implications for the activation induced by uridine nucleotides.
Wei Y; Lin J; Frey PA
Biochemistry; 2001 Sep; 40(37):11279-87. PubMed ID: 11551228
[TBL] [Abstract][Full Text] [Related]
8. Molecular dynamics, residue network analysis, and cross-correlation matrix to characterize the deleterious missense mutations in GALE causing galactosemia III.
Kumar SU; Sankar S; Kumar DT; Younes S; Younes N; Siva R; Doss CGP; Zayed H
Cell Biochem Biophys; 2021 Jun; 79(2):201-219. PubMed ID: 33555556
[TBL] [Abstract][Full Text] [Related]
9. Mediators of galactose sensitivity in UDP-galactose 4'-epimerase-impaired mammalian cells.
Schulz JM; Ross KL; Malmstrom K; Krieger M; Fridovich-Keil JL
J Biol Chem; 2005 Apr; 280(14):13493-502. PubMed ID: 15701638
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of UDP-sugar binding to UDP-galactose 4-epimerase from Escherichia coli.
Thoden JB; Hegeman AD; Wesenberg G; Chapeau MC; Frey PA; Holden HM
Biochemistry; 1997 May; 36(21):6294-304. PubMed ID: 9174344
[TBL] [Abstract][Full Text] [Related]
11. Altered cofactor binding affects stability and activity of human UDP-galactose 4'-epimerase: implications for type III galactosemia.
McCorvie TJ; Liu Y; Frazer A; Gleason TJ; Fridovich-Keil JL; Timson DJ
Biochim Biophys Acta; 2012 Oct; 1822(10):1516-26. PubMed ID: 22613355
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of disease-causing mutations in human UDP-galactose 4-epimerase.
Timson DJ
FEBS J; 2005 Dec; 272(23):6170-7. PubMed ID: 16302980
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis for severe epimerase deficiency galactosemia. X-ray structure of the human V94m-substituted UDP-galactose 4-epimerase.
Thoden JB; Wohlers TM; Fridovich-Keil JL; Holden HM
J Biol Chem; 2001 Jun; 276(23):20617-23. PubMed ID: 11279193
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of mutations in UDP-galactose-4-epimerase (GALE) associated with galactosemia in Korean patients using mammalian GALE-null cells.
Bang YL; Nguyen TT; Trinh TT; Kim YJ; Song J; Song YH
FEBS J; 2009 Apr; 276(7):1952-61. PubMed ID: 19250319
[TBL] [Abstract][Full Text] [Related]
15. Human UDP-galactose 4' epimerase (GALE) gene and identification of five missense mutations in patients with epimerase-deficiency galactosemia.
Maceratesi P; Daude N; Dallapiccola B; Novelli G; Allen R; Okano Y; Reichardt J
Mol Genet Metab; 1998 Jan; 63(1):26-30. PubMed ID: 9538513
[TBL] [Abstract][Full Text] [Related]
16. Crystal structures of the oxidized and reduced forms of UDP-galactose 4-epimerase isolated from Escherichia coli.
Thoden JB; Frey PA; Holden HM
Biochemistry; 1996 Feb; 35(8):2557-66. PubMed ID: 8611559
[TBL] [Abstract][Full Text] [Related]
17. Trypanosoma brucei UDP-galactose-4'-epimerase in ternary complex with NAD+ and the substrate analogue UDP-4-deoxy-4-fluoro-alpha-D-galactose.
Alphey MS; Burton A; Urbaniak MD; Boons GJ; Ferguson MA; Hunter WN
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Sep; 62(Pt 9):829-34. PubMed ID: 16946458
[TBL] [Abstract][Full Text] [Related]
18. Structure of an antibiotic-synthesizing UDP-glucuronate 4-epimerase MoeE5 in complex with substrate.
Sun H; Ko TP; Liu W; Liu W; Zheng Y; Chen CC; Guo RT
Biochem Biophys Res Commun; 2020 Jan; 521(1):31-36. PubMed ID: 31653344
[TBL] [Abstract][Full Text] [Related]
19. Characterization of two mutations associated with epimerase-deficiency galactosemia, by use of a yeast expression system for human UDP-galactose-4-epimerase.
Quimby BB; Alano A; Almashanu S; DeSandro AM; Cowan TM; Fridovich-Keil JL
Am J Hum Genet; 1997 Sep; 61(3):590-8. PubMed ID: 9326324
[TBL] [Abstract][Full Text] [Related]
20. UDP-galactose 4-epimerase: NAD+ content and a charge-transfer band associated with the substrate-induced conformational transition.
Liu Y; Vanhooke JL; Frey PA
Biochemistry; 1996 Jun; 35(23):7615-20. PubMed ID: 8652544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
